Press Release

High-throughput Screening Market 2019: Comprehensive Analysis by Top Key Companies, Industry Growth, Size, Share, Market Insights, Sales Volume and Forecast to 2024


The “High-throughput Screening Market” research report 2019-2024 delivers comprehensive information and valuable insights about the High-throughput Screening industry. The information available in the High-throughput Screening market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. High-throughput Screening market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the High-throughput Screening Market:

  • Agilent Technologies Inc.
  • Axxam SpA
  • Beckman Coulter Inc.
  • Bio
  • Rad Laboratories Inc.
  • Danaher Corporation
  • GE Healthcare
  • Merck KGaA
  • PerkinElmer Inc.
  • Tecan Group Ltd
  • Thermo Fisher Scientific Inc.

    Get a Sample Copy of the Report –

    Market Overview:

  • The high-throughput screening market is expected to register a CAGR of 7.8%, during the forecast period. North America dominates the market, owing to large spending on pharmaceutical R&D and high adoption of high-throughput screening technology in drug discovery.
  • The high-throughput screening (HTS) centers in the public domain have increased significantly over the past decade, ranging in size, from modestly-equipped academic screening centers to well-endowed molecular libraries probe centers network (MLPCN). These centers facilitate a comprehensive approach to probe discovery in academia, and utilize, both, standard and innovative assay technologies for executing primary and secondary screening campaigns. One of the significant advantages of these centers was knowledge sharing among scientists, researchers, etc. In European countries, EU-open-screen, European counterpart of US NIH initiative, is also working to get open access to all European organizations involved in chemical biology. Additionally, the association of HTS centers is also emerging, which is aimed at sharing valuable information about the compound or target, or the whole process. The open access provides a better platform for knowledge sharing, and can help optimize the entire process, which may drive the demand for HTS technology among end users.
  • HTS systems allow tens of thousands or even hundreds of thousands of compounds to be evaluated in a single day. As the throughput increases, the amount of data for each experiment increases, and scientists analyze and derive results from large amounts of data. Due to the sheer number of samples being processed and the massive volume of data being produced, the need for extensive automation techniques arises, to streamline the operations. However, automation requires massive investments for the establishment of machinery and supporting architecture, which are roadblocks for small- and moderate-size research institutes. Thus, the high costs associated with automation techniques can limit the market expansion.

    Scope of the Report:

  • The high-throughput screening market has been segmented by technology, applications, products and services, end user, and geography. By technology, the market is divided into an ultra-high-throughput screening, cell-based assays, lab-on-a-chip, and label-free technology. By application, the market has been subdivided into target identification, primary screening, and toxicology. By products and services, the market has been segmented into instruments, reagents and kits, and services. By end user, the market has been segmented into pharmaceutical and biotechnology firms, academia and research institutes, and contract research organizations.

    Reasons for Buying High-throughput Screening Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at –

    Key Market Trends:

    Pharmaceutical and Biotechnology Firms Represent the Largest End Users of High-throughput Screening Modalities.

    In order to gain sustainable competitive advantage, most of the large and small biotechnology and pharmaceutical companies are focusing on the development of novel molecules for the treatment of several chronic conditions. The need for rapid and precise screening of several target molecules, during drug discovery and development phases, has led to the adoption of automated high-throughput screening techniques to screen massive chemical and biomarker libraries generated during the research processes. Since an automated HTS system can test 10,000 to 100,000 target compounds per day, and uHTS can test more than 100,000 compounds per day, their adoption for drug discovery and development process has resulted in the market expansion.

    North America is Expected to Dominate the Market

    North America dominates the global high-throughput screening market, owing to the high adoption rate of HTS in the United States. The growth of the US high-throughput screening market can be attributed to the significant advances in combinatorial chemistry and the field of genomics. In addition, huge investments by the pharmaceutical industry, for HTS technologies, in terms of automation, miniaturization, and assay methodology, have further helped in the growth of the market. Furthermore, the end users of this market have witnessed increasing numbers of leads, clinical candidates, and marketed drugs arising from high-throughput screening.

    High-throughput Screening Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) –

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of High-throughput Screening Market Report 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Open Access to High-throughput Screening Laboratories
    4.2.2 Technological Advancements in HTS
    4.2.3 Increasing Usage in Universities and Research Centers
    4.3 Market Restraints
    4.3.1 High Capital Investment
    4.3.2 Need for Extensive Automation Techniques
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Technology
    5.1.1 Ultra-high-throughput Screening
    5.1.2 Cell-based Assays
    5.1.3 Lab-on-a-chip
    5.1.4 Label-free Technology
    5.2 By Applications
    5.2.1 Target Identification
    5.2.2 Primary Screening
    5.2.3 Toxicology
    5.3 By Products and Services
    5.3.1 Instruments
    5.3.2 Reagents and Kits
    5.3.3 Services
    5.4 By End Users
    5.4.1 Pharmaceutical and Biotechnology Firms
    5.4.2 Academia and Research Institutes
    5.4.3 Contract Research Organizations
    5.5 Geography
    5.5.1 North America US Canada Mexico
    5.5.2 Europe Germany UK France Italy Spain Rest of Europe
    5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.5.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.5.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Agilent Technologies Inc.
    6.1.2 Axxam SpA
    6.1.3 Beckman Coulter Inc.
    6.1.4 Bio-Rad Laboratories Inc.
    6.1.5 Danaher Corporation
    6.1.6 GE Healthcare
    6.1.7 Merck KGaA
    6.1.8 PerkinElmer Inc.
    6.1.9 Tecan Group Ltd
    6.1.10 Thermo Fisher Scientific Inc.



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Human Microbiome Market Size, share 2019-Global Business Trends, Share, Progress Insight, Modest Analysis, Statistics, Regional Demands, And Forecast to 2024

    Global Plant Squalane Market Share, Size 2019 Movements by Trend Analysis, Progression Status, Revenue Expectation to 2024 | Research Report by Industry Research.Biz

    Phototherapy Market Research Report 2019: Global Business Overview, Size, Revenue, And Outlook with Forecast 2024

    Global Red Clover Market 2019 Supply, Consumption, Cost and Profit analysis and forecast to 2025

  • Alfredoo Epps

    Alfredo Epps is a finance expert heading the petroleum column. He joined the group last year as an associate writer. But his thorough research skills and ability to seamlessly putting numerical data into words helped him get a senior position. Apart from a column head, Alfredo is a dancer and a violinist.

    Related Articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *